“Envbiotics” -- a novel framework for microbiota-targeted therapeutic strategies in type 2 diabetes mellitus - Takeaways - MDSpire

“Envbiotics” -- a novel framework for microbiota-targeted therapeutic strategies in type 2 diabetes mellitus

  • By

  • Wenxiao Wang

  • Long Xu

  • Ping Leng

  • Man Jiang

  • Xiaomin Xing

  • Mingchen Cao

  • Fanbo Jing

  • July 8, 2026

  • 0 min

Share

  • 1

    Imbalance of gut microbiota triggers insulin resistance in type 2 diabetes mellitus (T2DM).

  • 2

    Envbiotics are defined as substances that optimize the intestinal microenvironment and regulate microbiota without nutritional supplementation.

  • 3

    Existing microbiota-targeted therapies have limitations, including low glucose disposal response rates and individual variability.

  • 4

    Natural active compounds like berberine and urolithin A require metabolic transformation by gut microbiota to enhance their effects.

  • 5

    Envbiotics provide a new strategy for microbial-targeted intervention in T2DM, filling gaps in existing therapeutic approaches.

Original Source(s)

“Envbiotics” -- a novel framework for microbiota-targeted therapeutic strategies in type 2 diabetes mellitus

  • by Wenxiao Wang, Long Xu, Ping Leng, Man Jiang, Xiaomin Xing, Mingchen Cao, Fanbo Jing

  • July 8, 2026

Related Content

Takotsubo cardiomyopathy concurrent with hyperthyroidism following COVID-19—a case report and literature review

The association between C-reactive protein-triglyceride glucose index and all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a single-center retrospective cohort study

Comparative accuracy of 1-hour post-load plasma glucose, glycated albumin, and conventional glycemic measures for the diagnosis of type 2 diabetes mellitus: a systematic review and network meta-analysis